Computer illustration of cytotoxic T-lymphocytes attacking a cancer cell. UConn Health researchers are developing a technology that can identify which patients will respond to immunotherapy, with the goal of extending the benefits of the treatment to a wider group of patients. (Juan Gaertner/Science Photo Library via Getty Images)